AI Briefing#bispecific-antibodies
The latest AI and developer news about #bispecific-antibodies, with the original source and a short summary.
The latest AI and developer news about #bispecific-antibodies, with the original source and a short summary.
The acquisition allows Mithril to continue developing bispecific antibodies for LAMA2-CMD and other ECM-related genetic diseases with expanded resources and infrastructure.